Mercaptamine and anaemia Patient Reports February 13, 2012

Mercaptamine Side Effects Report #5928330-2
Mercaptamine side effect was reported by a Consumer or non-health professional from FRANCE on Oct 06, 2008. Female patient, child 12 years of age, was diagnosed with cystinosis and was treated with Mercaptamine. After drug was administered, patient experienced the following side effects: amnesia, anaemia, cerebral atrophy, convulsion, encephalopathy, gastrointestinal disorder, gastrooesophageal reflux disease, haemodialysis, neurological decompensation. Mercaptamine dosage: 44 MG/KG;DAILY; 89 MG/KG;DAILY. During the same period patient was treated with MERCAPTAMINE BITARTRATE, MERCAPTAMINE BITARTRATE, MERCAPTAMINE BITARTRATE, LAMOTRIGINE, PHENYTOIN , RANITIDINE, NIFEDIPINE, THYROXINE . Patient was hospitalized. Patient recovered.

Mercaptamine Side Effects Report #5220986-5
Mercaptamine side effect was reported by a Health Professional from FRANCE on Jan 08, 2007. Male patient, child 10 years of age, was diagnosed with cystinosis and was treated with Mercaptamine. After drug was administered, patient experienced the following side effects: abasia, abnormal behaviour, agitation, anaemia, arthralgia, asthenia, attention deficit/hyperactivity disorder, biopsy skin abnormal, blood parathyroid hormone decreased. Mercaptamine dosage: unknown. During the same period patient was treated with CYSTEAMINE, LEVOTHYROXINE, GROWTH HORMONE RECOMBINANT, EPOGEN, ACE INHIBITOR NOS. Patient recovered.

Mercaptamine Side Effects Report #5103000-1
Mercaptamine side effect was reported by a Pharmacist from FRANCE on Aug 24, 2006. Male patient, child 10 years of age, was diagnosed with cystinosis and was treated with Mercaptamine. After drug was administered, patient experienced the following side effects: abasia, abnormal behaviour, agitation, anaemia, arthralgia, asthenia, attention deficit/hyperactivity disorder, blood calcium decreased, blood parathyroid hormone decreased. Mercaptamine dosage: unknown. During the same period patient was treated with CYSTEAMINE, GROWTH HORMONE, ERYTHROPOIETIN, ACE INHIBITOR NOS. Patient recovered.